Maintenance of sinus rhythm with dronedarone in patients with atrial fibrillation or flutter - EURIDIS and ADONIS

Description:

The goal of the trials were to evaluate the safety and efficacy of dronedarone, a novel antiarrhythmic agent that is a derivative of amiodarone, compared with placebo among patients with atrial fibrillation (AF) or atrial flutter (AFL).